PIM
IONS icon

Partner Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Partner Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,094
Closed -$531K – 107
2016
Q4 		$531K Sell
11,094
-3,809
-26% -$151K 0.7% 50
2016
Q3 		$546K Buy
+14,903
New +$466K 0.81% 49

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Partner Investment Management's IONS Position: Q1 2017 in Review

Partner Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2017, closing a stake of 11,094 shares — an estimated $531K sold.

Partner Investment Management first reported a position in IONS in Q3 2016 and held it in 2 quarters. The position peaked at $546K in Q3 2016. 270 funds tracked by Wall St. Rank hold IONS as of Q1 2017.

  • Partner Investment Management reported no remaining Ionis Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Partner Investment Management sold 11,094 Ionis Pharmaceuticals shares in Q1 2017, an estimated $531K.
  • Partner Investment Management first reported a position in Ionis Pharmaceuticals in Q3 2016 and held it in 2 quarters.
  • Partner Investment Management's Ionis Pharmaceuticals position peaked at $546K in Q3 2016.
  • 270 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2017.

Based on Partner Investment Management's 13F filing for Q1 2017, filed 15 May 2017.